CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Series A convertible preferred stock Preferred Stock |
Balance (in Value) at Dec. 31, 2020 | $ 138.8 | | $ 401.6 | $ (327.8) | | $ 65 |
Balance (in Shares) at Dec. 31, 2020 | | 65,023,174 | | | | 650,000 |
Exercise of options (in Value) | 0.6 | | 0.6 | | | |
Exercise of options (in shares) | | 149,545 | | | | |
Vesting of restricted stock units (in Value) | (0.8) | | (0.8) | | | |
Vesting of restricted stock units (in Shares) | | 5,737 | | | | |
Series A convertible preferred stock dividend | (1.2) | | | (1.2) | | |
Stock-based compensation expense | 1.4 | | 1.4 | | | |
Foreign currency translation adjustments | 0.2 | | | | $ 0.2 | |
Net income (loss) | (7.3) | | | (7.3) | | |
Balance (in Value) at Mar. 31, 2021 | 131.7 | | 402.8 | (336.3) | 0.2 | $ 65 |
Balance (in Shares) at Mar. 31, 2021 | | 65,178,456 | | | | 650,000 |
Balance (in Value) at Dec. 31, 2020 | 138.8 | | 401.6 | (327.8) | | $ 65 |
Balance (in Shares) at Dec. 31, 2020 | | 65,023,174 | | | | 650,000 |
Net income (loss) | 48.9 | | | | | |
Balance (in Value) at Sep. 30, 2021 | 168.5 | | 386.2 | (282.6) | (0.1) | $ 65 |
Balance (in Shares) at Sep. 30, 2021 | | 62,485,747 | | | | 650,000 |
Balance (in Value) at Mar. 31, 2021 | 131.7 | | 402.8 | (336.3) | 0.2 | $ 65 |
Balance (in Shares) at Mar. 31, 2021 | | 65,178,456 | | | | 650,000 |
Vesting of restricted stock units (in Value) | (0.3) | | (0.3) | | | |
Vesting of restricted stock units (in Shares) | | 143,601 | | | | |
Series A convertible preferred stock dividend | (1.3) | | | (1.3) | | |
Common stock repurchased and retired(Shares) | | (1,517,623) | | | | |
Common stock repurchased and retired,Value | (10.5) | | (10.5) | | | |
Stock-based compensation expense | 2.9 | | 2.9 | | | |
Foreign currency translation adjustments | 0.2 | | | | 0.2 | |
Net income (loss) | 35.3 | | | 35.3 | | |
Balance (in Value) at Jun. 30, 2021 | 158 | | 394.9 | (302.3) | 0.4 | $ 65 |
Balance (in Shares) at Jun. 30, 2021 | | 63,804,434 | | | | 650,000 |
Exercise of options (in Value) | (0.1) | | (0.1) | | | |
Exercise of options (in shares) | | 8,000 | | | | |
Vesting of restricted stock units (in Value) | (0.9) | | (0.9) | | | |
Vesting of restricted stock units (in Shares) | | 155,690 | | | | |
Series A convertible preferred stock dividend | (1.2) | | | (1.2) | | |
Common stock repurchased and retired(Shares) | | (1,482,377) | | | | |
Common stock repurchased and retired,Value | (9.8) | | (9.8) | | | |
Stock-based compensation expense | 2.1 | | 2.1 | | | |
Foreign currency translation adjustments | (0.5) | | | | (0.5) | |
Net income (loss) | 20.9 | | | 20.9 | | |
Balance (in Value) at Sep. 30, 2021 | 168.5 | | 386.2 | (282.6) | (0.1) | $ 65 |
Balance (in Shares) at Sep. 30, 2021 | | 62,485,747 | | | | 650,000 |
Balance (in Value) at Dec. 31, 2021 | 176 | | 387.8 | (276.8) | | $ 65 |
Balance (in Shares) at Dec. 31, 2021 | | 62,489,278 | | | | 650,000 |
Exercise of options (in Value) | 0.8 | | 0.8 | | | |
Exercise of options (in shares) | | 91,425 | | | | |
Exercise of warrants (in shares) | | 817,648 | | | | |
Exercise of warrants (Values) | 9.4 | | 9.4 | | | |
Vesting of restricted stock units (in Shares) | | 43,450 | | | | |
Series A convertible preferred stock dividend | (1.2) | | | (1.2) | | |
Stock-based compensation expense | 2.2 | | 2.2 | | | |
Net income (loss) | 13 | | | 13 | | |
Balance (in Value) at Mar. 31, 2022 | 200.2 | | 400.2 | (265) | | $ 65 |
Balance (in Shares) at Mar. 31, 2022 | | 63,441,801 | | | | 650,000 |
Balance (in Value) at Dec. 31, 2021 | 176 | | 387.8 | (276.8) | | $ 65 |
Balance (in Shares) at Dec. 31, 2021 | | 62,489,278 | | | | 650,000 |
Net income (loss) | 43.3 | | | | | |
Balance (in Value) at Sep. 30, 2022 | 231.6 | | 404.3 | (237.2) | (0.5) | $ 65 |
Balance (in Shares) at Sep. 30, 2022 | | 63,551,566 | | | | 650,000 |
Balance (in Value) at Mar. 31, 2022 | 200.2 | | 400.2 | (265) | | $ 65 |
Balance (in Shares) at Mar. 31, 2022 | | 63,441,801 | | | | 650,000 |
Vesting of restricted stock units (in Value) | $ (0.2) | | (0.2) | | | |
Vesting of restricted stock units (in Shares) | 62,217 | | | | | |
Series A convertible preferred stock dividend | $ (1.2) | | | (1.2) | | |
Stock-based compensation expense | 2.3 | | 2.3 | | | |
Foreign currency translation adjustments | (0.1) | | | | (0.1) | |
Net income (loss) | 17.7 | | | 17.7 | | |
Balance (in Value) at Jun. 30, 2022 | 218.7 | | 402.3 | (248.5) | (0.1) | $ 65 |
Balance (in Shares) at Jun. 30, 2022 | | 63,504,018 | | | | 650,000 |
Vesting of restricted stock units (in Value) | (0.1) | | (0.1) | | | |
Vesting of restricted stock units (in Shares) | | 47,548 | | | | |
Series A convertible preferred stock dividend | (1.3) | | | (1.3) | | |
Stock-based compensation expense | 2.1 | | 2.1 | | | |
Foreign currency translation adjustments | (0.4) | | | | (0.4) | |
Net income (loss) | 12.6 | | | 12.6 | | |
Balance (in Value) at Sep. 30, 2022 | $ 231.6 | | $ 404.3 | $ (237.2) | $ (0.5) | $ 65 |
Balance (in Shares) at Sep. 30, 2022 | | 63,551,566 | | | | 650,000 |